108 related articles for article (PubMed ID: 3924761)
1. Post-transfusion graft-vs-host disease (GVHD): immunopathology and prevention.
Fagiolo E; D'Addosio AM
Haematologica; 1985; 70(1):62-74. PubMed ID: 3924761
[No Abstract] [Full Text] [Related]
2. [Prevention of graft vs. host disease in pediatric post-transfusion patients].
Buñuel Guillén C; Buñuel Alvarez JC
An Esp Pediatr; 1991 May; 34(5):335-7. PubMed ID: 1883105
[No Abstract] [Full Text] [Related]
3. An immunohistological study of post-transfusion graft-versus-host disease (GVHD).
Hojo H; Kainuma Y; Kunori T; Wachi E; Wakasa H
Fukushima J Med Sci; 1993 Dec; 39(2):77-87. PubMed ID: 7927138
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute post-transfusion- graft-versus-host disease (GVHD) with intravenous human immunoglobulins: a case report.
Orlandi C; Frassetto A; Gnucci E; Lehmann JR; Neri R; Melandri D
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):760-1. PubMed ID: 16836524
[No Abstract] [Full Text] [Related]
5. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
[No Abstract] [Full Text] [Related]
6. [Posttransfusion graft vs host disease].
Muñoz MC; Hernández M; Rifón J; Panizo C; Rodríguez M
Sangre (Barc); 1998 Feb; 43(1):55-8. PubMed ID: 9580428
[No Abstract] [Full Text] [Related]
7. Prevention of post-transfusion graft-versus-host disease.
Tasaki T; Ohto H; Abe R
Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133
[TBL] [Abstract][Full Text] [Related]
8. Transfusion-associated graft-vs-host disease in patients with malignancies. Report of two cases and review of the literature.
Decoste SD; Boudreaux C; Dover JS
Arch Dermatol; 1990 Oct; 126(10):1324-9. PubMed ID: 2221937
[TBL] [Abstract][Full Text] [Related]
9. Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation.
Ma SY; Au WY; Lie AK; Ng IO; Leung AY; Tse EW; Liang RH; Lau GK; Kwong YL
Bone Marrow Transplant; 2004 Jul; 34(1):57-61. PubMed ID: 15156162
[TBL] [Abstract][Full Text] [Related]
10. Transfusion-associated graft-versus-host disease.
Dwyre DM; Holland PV
Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
[TBL] [Abstract][Full Text] [Related]
11. An autopsy report of graft-versus-host disease (GVHD) following blood transfusion.
Otori K; Masuda C; Wanibuchi H; Nakanishi A; Kawabata K; Ohashi H; Fukushima S
Osaka City Med J; 1999 Jun; 45(1):37-43. PubMed ID: 10723200
[TBL] [Abstract][Full Text] [Related]
12. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Prevention of graft-vs.-host disease.
Woods WG
Am J Pediatr Hematol Oncol; 1984; 6(3):283-6. PubMed ID: 6393792
[TBL] [Abstract][Full Text] [Related]
13. Nonlethal, attenuated, transfusion-associated graft-versus-host disease in an immunocompromised child: case report and review of the literature.
Neves JF; Marques A; Valente R; Barata D
Transfusion; 2010 Nov; 50(11):2484-8. PubMed ID: 20497511
[TBL] [Abstract][Full Text] [Related]
14. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Huang XJ; Jiang Q; Chen H; Xu L; Liu D; Chen Y; Han W; Zhang Y; Liu K; Lu D
Bone Marrow Transplant; 2005 Aug; 36(4):343-8. PubMed ID: 15968295
[TBL] [Abstract][Full Text] [Related]
15. Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factors.
Wang XN; Collin M; Sviland L; Marshall S; Jackson G; Schulz U; Holler E; Karrer S; Greinix H; Elahi F; Hromadnikova I; Dickinson AM
Biol Blood Marrow Transplant; 2006 Feb; 12(2):152-9. PubMed ID: 16443513
[TBL] [Abstract][Full Text] [Related]
16. Transfusion associated graft versus host disease.
Gupta A; Bansal D; Dass R; Das A
Indian Pediatr; 2004 Dec; 41(12):1260-4. PubMed ID: 15623910
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-associated graft-versus-host disease: an overview and two case reports.
Spector D
Oncol Nurs Forum; 1995; 22(1):97-101. PubMed ID: 7708528
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood.
Gruhn B; Häfer R; Kosmehl H; Fuchs D; Zintl F
Bone Marrow Transplant; 1998 May; 21(9):901-7. PubMed ID: 9613782
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
20. Role of target organ infection with cytomegalovirus in the pathogenesis of graft-versus-host disease.
Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Proctor SJ; Hamilton PJ; Cant AJ
Bone Marrow Transplant; 1995 Apr; 15(4):557-61. PubMed ID: 7655381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
